Exogenous control of cardiac gene therapy: Evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters
Open Access
- 31 July 1999
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 118 (1) , 26-34
- https://doi.org/10.1016/s0022-5223(99)70137-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Immunology of gene therapy with adenoviral vectors in mouse skeletal muscleHuman Molecular Genetics, 1996
- Regulatable Promoters for Use in Gene Therapy Applications: Modification of the 5′-Flanking Region of the CFTR Gene with Multiple cAMP Response Elements to Support Basal, Low-Level Gene Expression That Can Be Upregulated by Exogenous Agents That Raise Intracellular Levels of cAMPHuman Gene Therapy, 1996
- Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter systemMolecular Brain Research, 1996
- Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors.Circulation, 1994
- Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosisNature Genetics, 1994
- Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results.Circulation Research, 1993
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase geneCell, 1987
- A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirusCell, 1985
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979